Exosens Statistics

Total Valuation

Exosens has a market cap or net worth of EUR 2.06 billion. The enterprise value is 2.23 billion.

Market Cap	2.06B
Enterprise Value	2.23B

Important Dates

The last earnings date was Wednesday, July 30, 2025.

Earnings Date	Jul 30, 2025
Ex-Dividend Date	May 28, 2025

Share Statistics

Current Share Class	50.76M
Shares Outstanding	n/a
Shares Change (YoY)	+56.36%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	29.78M

Valuation Ratios

The trailing PE ratio is 36.89 and the forward PE ratio is 25.66.

PE Ratio	36.89
Forward PE	25.66
PS Ratio	4.76
PB Ratio	4.79
P/TBV Ratio	29.47
P/FCF Ratio	36.01
P/OCF Ratio	20.33
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.51, with an EV/FCF ratio of 39.14.

EV / Earnings	40.10
EV / Sales	5.18
EV / EBITDA	20.51
EV / EBIT	24.49
EV / FCF	39.14

Financial Position

The company has a current ratio of 2.51, with a Debt / Equity ratio of 0.63.

Current Ratio	2.51
Quick Ratio	1.61
Debt / Equity	0.63
Debt / EBITDA	2.46
Debt / FCF	4.70
Interest Coverage	6.10

Financial Efficiency

Return on equity (ROE) is 13.73% and return on invested capital (ROIC) is 8.51%.

Return on Equity (ROE)	13.73%
Return on Assets (ROA)	6.91%
Return on Invested Capital (ROIC)	8.51%
Return on Capital Employed (ROCE)	12.29%
Revenue Per Employee	308,360
Profits Per Employee	39,804
Employee Count	1,401
Asset Turnover	0.52
Inventory Turnover	1.72

Taxes

In the past 12 months, Exosens has paid 19.49 million in taxes.

Income Tax	19.49M
Effective Tax Rate	25.91%

Stock Price Statistics

The stock price has increased by +99.80% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+99.80%
50-Day Moving Average	40.50
200-Day Moving Average	30.31
Relative Strength Index (RSI)	48.70
Average Volume (20 Days)	110

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Exosens had revenue of EUR 431.70 million and earned 55.73 million in profits. Earnings per share was 1.09.

Revenue	431.70M
Gross Profit	258.68M
Operating Income	91.26M
Pretax Income	75.21M
Net Income	55.73M
EBITDA	104.56M
EBIT	91.26M
Earnings Per Share (EPS)	1.09

Full Income Statement

Balance Sheet

The company has 89.79 million in cash and 268.44 million in debt, giving a net cash position of -178.66 million.

Cash & Cash Equivalents	89.79M
Total Debt	268.44M
Net Cash	-178.66M
Net Cash Per Share	n/a
Equity (Book Value)	429.50M
Book Value Per Share	8.46
Working Capital	188.99M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 101.11 million and capital expenditures -44.02 million, giving a free cash flow of 57.09 million.

Operating Cash Flow	101.11M
Capital Expenditures	-44.02M
Free Cash Flow	57.09M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 59.92%, with operating and profit margins of 21.14% and 12.91%.

Gross Margin	59.92%
Operating Margin	21.14%
Pretax Margin	17.42%
Profit Margin	12.91%
EBITDA Margin	24.22%
EBIT Margin	21.14%
FCF Margin	13.23%

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.25%.

Dividend Per Share	0.10
Dividend Yield	0.25%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	9.11%
Buyback Yield	-56.36%
Shareholder Yield	-56.11%
Earnings Yield	2.71%
FCF Yield	2.78%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Exosens has an Altman Z-Score of 3.03 and a Piotroski F-Score of 6.

Altman Z-Score	3.03
Piotroski F-Score	6